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ABSTRACT
Different RNA species are rigorously discriminated
and exported by distinct export factors, but this
discrimination mechanism remains largely unknown.
We previously showed, by RNA microinjection
experiments, that intronless mRNAs are discrimi-
nated from U snRNAs based on their difference in
RNA length. However, it was unclear how they are
discriminated in the natural situation in which their
nascent transcripts emerge progressively during
transcription. We hypothesized that transcription
from the corresponding promoters is important for
this discrimination. Here we show that contrary to
our hypothesis, the discrimination process was not
significantly influenced by whether transcription
occurred from an mRNA- versus a U snRNA-type
promoter. Rather, the features of transcribed RNAs
determined the RNA identity, consistent with our
previous results of RNA microinjection. Moreover,
we found that the poly (A) tail can function as an
identity element for mRNA export. The presence of a
poly (A) tail of an appropriate length committed
otherwise short Pol II transcripts to the mRNA export
pathway in a dominant manner, indicating that the
poly (A) tail either contributes to increasing the RNA
length or functions as a platform to recruit mRNA
export factors. Our results reveal a novel function of
the poly (A) tail in mRNA export.
INTRODUCTION
The nuclear envelope separates eukaryotic cells into two
major compartments, the nucleus and the cytoplasm. This
separation requires transport between the two compart-
ments through the nuclear pore complexes, the channels
embedded in the nuclear envelope (1). The vast majority of
RNA species, following their transcription and processing
in the nucleus, are exported to the cytoplasm. Diﬀerent
RNA species, such as tRNAs, U snRNAs, mRNAs and
rRNAs, utilize distinct export pathways, i.e. distinct sets
of export factors (2,3). Accumulating evidence shows that
the pathway of RNA export can inﬂuence the fate of
a given RNA in the cytoplasm (4–8), indicating the
biological importance of the choice of RNA export
pathway. This means that the cellular export machinery
must be able to discriminate distinct RNA species, and
therefore each RNA species should have identifying
features that specify its export pathway.
The mechanism of discrimination between U snRNAs
and mRNAs has been a focus of our research interest
because these two classes of RNA have similarities. Both
classes of RNA are transcribed by RNA polymerase II
and therefore both initially acquire a 7-methyl guanosine
cap (m7G-cap) structure. This common m7G-cap struc-
ture is essential for U snRNA export and stimulatory for
mRNA export (9–14). Importantly, neither class of RNA
has clearly conserved RNA sequences or structures that
may function as its distinguishing features, with the only
exceptions being the poly (A) tail for mRNAs and the
Sm-binding site for U snRNAs. Neither of these two
elements, however, is essential for RNA export per se
(9,10). Despite these similarities, these two classes of RNA
utilize distinct export factors.
Major spliceosomal U snRNAs such as U1, U2, U4 and
U5 are initially exported from the nucleus in Metazoa
(15,16). U snRNA export is mediated by the leucine-rich
nuclear export signal receptor CRM1, a member of the
importinb family (17–19). CRM1 binds indirectly to U
snRNAs through two adaptor proteins. One is the
heterodimeric Cap Binding Complex (CBC), which binds
speciﬁcally to the essential export signal of U snRNAs,
the m7G-cap structure (11,20,21). The other adaptor is
PHAX, which bridges the interaction between CRM1
and the CBC/U snRNA complex (22). PHAX has a
leucine-rich NES to which CRM1 binds cooperatively
with RanGTP. In this way these ﬁve proteins and a U
snRNA assemble into the export complex.
On the other hand, mRNA export is mediated by
distinct export factors. The principal export receptor for
mRNAs is TAP-p15 heterodimer (23–25). TAP is one
of the few non-importinb family transport receptors
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recruitment to mRNAs requires adaptor proteins. RNA-
binding adaptor proteins, including Aly/REF and shut-
tling SR proteins, are ﬁrst recruited to mRNA, and these
adaptor proteins in turn recruit mRNA export receptor
TAP-p15 heterodimer onto the RNA through protein–
protein interactions (26–32). Interestingly, SR proteins
only in their dephosphorylated state can recruit TAP-p15
(36,37). The m7G-cap structure of mRNAs is bound by
CBC, and the CBC binding can stimulate the recruitment
of adaptor proteins (13,14). However, the contribution of
the cap structure and CBC to mRNA export is lower than
in U snRNA export.
In attempts to search for the distinguishing features
between mRNAs and U snRNAs, we previously found
that the presence of introns in mRNA precursors is one
such feature. When a pre-mRNA intron was artiﬁcially
inserted into U1 snRNA, the spliced U1 snRNA was
exported via the mRNA export pathway instead of the U
snRNA pathway, indicating that introns can function as a
distinguishing feature of mRNAs, i.e. as an identity
element for mRNA export (7). It is very likely that this
identity element functions through splicing-dependent
deposition of protein complexes such as the exon junction
complex (EJC) and/or the transcription/export (TREX)
complex, both of which contain mRNA-speciﬁc RNA-
binding protein Aly/REF (13,31,33–35). Aly/REF as well
as some shuttling SR proteins in their dephosphorylated
state functions in recruiting the principal mRNA export
receptor, TAP/p15 heterodimer, onto the RNA, thus
inducing mRNA export (26–28,31,32,36,37).
We subsequently found that RNA length plays an
important role in the choice of RNA export pathway
(7,12). When U snRNA was elongated by inserting an
unstructured RNA fragment longer than 200–300nt, the
elongated U snRNA behaved like an mRNA in export.
Conversely, if an intronless mRNA was shortened (100nt
or shorter) by deletion, the shortened mRNA behaved like
a U snRNA in export. Taken together, these ﬁndings
indicate that the presence of a stretch of unstructured
RNA of a certain length can function as a splicing-
independent mRNA identity element (12).
The above two identity elements were identiﬁed by
RNA microinjection experiments using Xenopus oocytes
in which in vitro transcribed RNAs were microinjected
into the nucleus, and therefore in which RNA export was
not dependent on in vivo transcription. This experimental
system was advantageous for focusing on RNA export per
se, but on the other hand, it was not useful for examining
the inﬂuence of transcription on the identity of the
transcripts in nuclear export. More speciﬁcally, it was
not clear how these mRNA identity elements, especially
‘RNA length’, are recognized in the natural situation in
which the nascent transcripts emerge progressively as
transcription proceeds. Therefore, we hypothesized that
transcription from the two corresponding promoters,
namely the mRNA- or U snRNA-type promoter, may
be important for the discrimination between the nascent
transcripts of mRNAs and U snRNAs in vivo.
The mRNA-type promoters and the U snRNA-type
promoters have distinct cis-elements for transcription (38).
Although RNA polymerase II is involved in transcribing
both types, the transcription from the U snRNA-type
promoters requires an additional set of transcription
factors termed the snRNA activating protein complex
(SNAPc) on top of the basic Pol II transcription factors
(38). It is well documented that diﬀerent promoters can
load diﬀerent protein factors, especially RNA processing
factors, onto the nascent transcripts (reviewed in 39–41,
also see 42–44). Some splicing factors and cleavage/
polyadenylation factors are loaded through transcription
from the mRNA-type promoters (39–41,45,46), whereas a
protein complex for 3’-end cleavage of U snRNAs, termed
‘Integrator’, is loaded through transcription from the U
snRNA-type promoters (47). Therefore, it was plausible to
hypothesize that speciﬁc export factors for mRNAs and U
snRNAs are loaded through transcription from the
corresponding promoters, leading to commitment to the
corresponding export pathways. In yeast, the recruitment
of adaptor proteins is coupled to transcription. Aly/REF
(Yra1p in yeast) together with DExD-box RNA helicase
UAP56 (Sub2p in yeast) interacts with the transcription
elongation complex (THO complex), forming a larger
protein complex termed TREX (transcription/export)
complex (48,49). Owing to this complex formation, Aly/
REF and UAP56 are recruited onto the nascent mRNA
transcript during transcription elongation (48,49).
Although the recruitment of the TREX complex is
known to be splicing-dependent in vertebrates (35), it is
still possible that transcription may be coupled to RNA
export in the case of intronless vertebrate genes.
In this study, we focused on the eﬀect of transcription
on the process of discrimination between intronless
mRNAs and UsnRNAs. Contrary to our initial expecta-
tion, whether transcription occurred from the mRNA- or
U snRNA-type promoter did not inﬂuence the discrimina-
tion process. Instead, the features of the transcribed
RNAs, rather than the ways they were transcribed, were
important for determining the identities of the RNAs for
nuclear export, as was previously shown by us in RNA
microinjection experiments (7,12). Moreover, during the
course of this study, we serendipitously found that the
presence of the poly (A) tail in the transcript can function
as an identity element for mRNA nuclear export. If a poly
(A) tail of an appropriate length was present on the
transcript, the transcript was committed to the mRNA
export pathway in a dominant manner, even when the
transcript without the poly (A) tail was too short to
behave like an mRNA, indicating that the poly (A) tail
either contributes to increasing the RNA length or
functions as a platform to speciﬁcally recruit mRNA
export factors. Our results reveal a novel role of the poly
(A) tail in mRNA nuclear export.
MATERIALS AND METHODS
DNA constructs
U1 gene derivatives: The Xenopus U1 gene was PCR-
ampliﬁed from Xenopus genomic DNA and the ampliﬁed
fragment was cloned in the EcoRI-HindIII sites of the
vector pUC118 (Takara). The Sm site of the cloned U1
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Various cDNA fragments were inserted into the XhoI site
as described previously (12). A DNA fragment containing
A70 sequence with XhoI and SalI sites was made by
annealing A70-containing oligo DNA with T70-contain-
ing oligo DNA. One or two copies of this DNA fragment
were inserted into the XhoI site of the U1 gene. cDNA
expression constructs without U1 sequence: Various
fragments were PCR-ampliﬁed from b-globin cDNA,
DHFR cDNA or the U5Sm gene as described previously
(12), except that EcoRV and XbaI sites were added to the
upstream and downstream DNA ends, respectively. The
100-nt DHFR fragment was PCR-ampliﬁed by the two
primers (50-GGAAGATCTGCATCATGGTTCGACCA
TTGA-30,5 0-AACTCGTTCCTGAGCGGAGGCGGAT
CCGCG-30). The fragment was digested by BglII and
BamHI and ligated to multimerize when necessary. The
multimerized fragments were PCR-ampliﬁed again to add
EcoRV and XbaI sites. The U1 promoter and the U1
terminator were PCR-ampliﬁed from the U1 gene with the
following two primer sets; 50-CCGGAATTCAAGCTTT
TGTACAAGGATTCA-30 and 50-ACGATATCGAGTT
GAACAAGAAATTTTCAA-30,o r5 0-GCTCTAGAATT
TTGTTTGTTTAAAGATAGA-30 and 50-CATAAGCTT
GATCTCTATCTTTAAACAAAC-30, respectively. The
CMV promoter and the BGH poly (A) signal were
PCR-ampliﬁed from the pcDNA3 plasmid (Invitrogen)
with the following two primer sets; 50-CCGGAATTCTG
TACGGGCCAGATATACGCG-30 and 50-TCAGATAT
CTCTAGTTAGCCAGAGAGCTCT-30,o r5 0-TGCTCT
AGACTAATAAAATGAGGAAATTGC-30 and 50-AAA
CTGCAGTTCCGCCTCAGAAGCCATAGA-30, respec-
tively. Various cDNA fragments were cloned between one
of the two promoter fragments and one of the two
terminator fragments, using EcoRI-PstI or EcoRI-HindIII
sites of pUC118.
Assay ofRNA export coupled toin vivotranscription
Microinjection into Xenopus oocytes was performed as
previously described (12), except that 17ng/oocyte of
various plasmids was microinjected instead of RNA, and
nuclear and cytoplasmic RNA was recovered at 3–4h
after microinjection and visualized by northern blotting
with speciﬁc probes. CTE and PHAXNES were
prepared as described (7,22).
Northern blotting
RNA samples were fractionated by 8% PAGE (7M Urea)
and transferred to Hybond N+ membranes (Amersham).
Hybridization with oligo DNA probes,
32P-labeled at the
50 termini, was performed in PerfectHybPlus (Sigma).
For detecting only polyadenylated transcripts, 50-TTTTT
TTTTTTTGCGATGCAATTTCCT-30 was used as a
probe at 538C. For detecting other transcripts, the follow-
ing probes were used at 408C; U1Sm: 50-ACTACCAGC
TCGAGTGCAGTCG-30, other U1 derivatives: 50-CTCG
AGTGCAGTCGAGTTTCCCGCA-30, DHFR100: 50-TC
TAGAAACTCGTTCCTGAGCGGAGGC-30, b-globin
cDNA-derived transcripts: 50-AGTGAACACAGTTGT
GTCAGAAGCAAATGTAAGCAAGCTTGTATTC-30,
Xenopus endogenous U6 RNA: 50-CAGGGGCCATGC
TAATCTTCTCT-30, Xenopus endogenous 5.8S RNA:
50-CGAAGTGTCGATGATCAATGTGTCC-30. Anal-
ysis and quantitation of the northern signal was
performed with BAS-2500 (FujiFilm) and Image Gauge
version 3.45 (FujiFilm).
RNA immunoprecipitation
Nuclear extract was prepared at 3h after microinjection
and immunoprecipitation was performed as described
previously (12). The precipitated RNA was treated with
RQ1 DNase (Promega) and analyzed by quantitative
PCR, using SuperScript III Platinum SYBR Green
One-Step qRT-PCR (Invitrogen) and a 7500 RealTime
PCR system (Applied Biosystems). The following PCR
primers were used. Non-polyadenylated b-globin
transcripts: 50-GAATACAAGCTTGCTTACATTTGC-30
and 50-TGCTAGTGAACACAGTTGTG-30. Polyadenyl-
ated b-globin transcripts: 50-GAATACAAGCTTGCT
TACATTTGC-30 and 50-TTTTTTTTTTTTTTTTTTTT
TGCGATGCAA-30. U1-derived transcripts: 50-ATACT
TACCTGGCAGGGGAG-30 and 50-TCCCCCACTAC
CAGCTCGAG-30.
RESULTS
RNA length isan important determinant ofRNA identity
innuclear export, evenin an RNA export assaysystem that
iscoupled to invivo transcription
To examine whether transcription in vivo inﬂuences
the discrimination between intronless mRNAs and U
snRNAs, we developed an RNA export assay system that
is coupled to in vivo transcription. To this end, DNA
fragments derived from U snRNA and/or mRNA
sequences were cloned downstream of either the U1
snRNA promoter (as a representative of U snRNA-type
promoters) or the cytomegalovirus (CMV) promoter (as a
representative of mRNA-type promoters) to initiate
transcription in vivo. We also inserted either the U1
snRNA terminator or the poly (A) signal from the bovine
growth hormone (BGH) gene downstream of the DNA
fragments to terminate transcription. The resultant
plasmids were microinjected into the nucleus of Xenopus
oocytes, and export of RNA transcripts produced in vivo
from the injected plasmids was examined by northern
blotting analysis with the nuclear and cytoplasmic RNA
fractions. The export pathways of the transcripts were
analyzed using pathway-speciﬁc export inhibitors.
We ﬁrst cloned the Xenopus laevis U1 snRNA gene
including its promoter and terminator, and introduced an
XhoI restriction site in place of the Sm-binding site near
the middle of the U1 sequence (Figure 1A). The U1 RNA
transcript with this modiﬁcation, called U1Sm RNA, is
exported eﬃciently but is defective in re-import into the
nucleus (9). When this mutant U1 plasmid was micro-
injected into the nucleus of Xenopus laevis oocytes, the U1
transcript produced in vivo from the plasmid was quite
uniform, forming a discrete single band as judged by
northern blotting analysis (Figure 1B, lanes 1, 2;
Figure 1D, lanes 1, 2). This is because the U1 terminator,
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transcript at a discreet site without adding additional
nucleotides (50). Examination of the nucleocytoplasmic
distribution of the U1 transcript revealed that the
transcript was mainly cytoplasmic (e.g. Figure 1D,
lanes 1,2), indicating that the U1 transcript was exported
eﬃciently. To determine the export pathway of the U1
transcript, two pathway-speciﬁc RNA export inhibitors
were employed. The ﬁrst was CTE (constitutive transport
element) from type D retroviruses, which speciﬁcally binds
to TAP-p15 and thereby inhibits mRNA export when a
saturating amount is injected (23,51). The second was a
dominant-negative mutant of a U snRNA export factor,
PHAX that lacks the NES sequence (PHAXNES) and
thus blocks U snRNA-CRM1 complex formation (22).
The nucleocytoplasmic distribution of the U1 transcript
was only slightly aﬀected by the co-injected wild-type
CTE, and not at all by a non-functional CTE mutant
(Figure 1B, compare lanes 1, 2 with 3, 4, see Figure 1C for
quantitation). In contrast, when the PHAXNES protein
was co-injected in place of CTE, export of the U1
transcript was strongly inhibited (Figure 1D, compare
lanes 1, 2 with 3, 4, and Figure 1E for quantitation). The
distributions of the endogenous U6 and 5.8S RNAs,
which are nuclear and cytoplasmic markers, respectively,
veriﬁed the eﬃcacy of the nuclear-cytoplasmic fractiona-
tion (Figure 1B and D; also see subsequent ﬁgures). This
result conﬁrmed that the U1 transcript produced from the
injected plasmid in the nucleus of Xenopus oocytes was
clearly exported by the canonical export pathway, the U
snRNA export pathway.
We previously showed, in microinjection experiments
with in vitro transcribed RNAs, that if U1 RNA was
progressively elongated by the insertion of cDNA frag-
ments of increasing length, the elongated U1 RNA was
progressively converted to utilize the mRNA export
pathway (12). If the insert was as short as 50nt, the
elongated U1 RNAs still behaved like a U snRNA during
Figure 1. Eﬀect of RNA length on RNA export in the transcription-coupled system (I). (A) Diagram of the DNA constructs. Human b-globin
cDNA fragments of various lengths were inserted into the XhoI site of the U1Sm gene. (B) The plasmids harboring the U1Sm genes with or
without the insertion of cDNA fragments of various lengths (50–300nt) were microinjected into the nucleus of Xenopus oocytes, with 17ng/oocyte of
either wild-type (WT) or mutant (mut) CTE, and the nucleocytoplasmic distribution of the transcripts was analyzed by northern blotting of nuclear
(N) and cytoplasmic (C) RNA fractions after 4h. The distribution of endogenous U6 snRNA (U6) and 5.8S rRNA (5.8S) was also analyzed by
northern blotting to verify the eﬃcacy of the nucleocytoplasmic fractionation. (C) Quantitation of RNA export inhibition by CTE WT from the
experiments as in B. Average inhibition and standard deviation were calculated (with CTE mut taken as standard) from three independent
experiments. (D) Plasmids harboring the U1Sm genes with or without the insertion of the cDNA fragments of 50 or 300nt were microinjected into
the nucleus, with 4.1ng/oocyte of the PHAXNES protein (+) or buﬀer ( ), and export of the transcripts was examined as in B, except that RNA
was isolated 3h after injection. (E) Quantitation of RNA export inhibition by PHAXNES from the experiments as in D. Average inhibition and
standard deviation were calculated (with buﬀer taken as standard) from three independent experiments.
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the elongated U1 RNAs behaved overall like an mRNA
(12). To test if this was also the case with our current RNA
export assay system that is coupled to in vivo transcrip-
tion, the U1Sm gene was progressively elongated by the
insertion of human b-globin cDNA fragments of various
lengths (50–300nt) into the XhoI site (Figure 1A), and the
resultant plasmids carrying these elongated U1 genes were
microinjected into the nucleus of Xenopus oocytes for the
RNA export assay (Figure 1B–E).
The U1-derived transcripts were overall exported eﬃ-
ciently (Figure 1B–D). The export of relatively short
U1-derivedtranscripts,inwhichab-globincDNAsequence
of 50 or 100nt was inserted, was only weakly aﬀected by
CTE, but was strongly inhibited by PHAXNES
(Figure 1B, lanes 5–12, Figure 1D, lanes 5–8, and 1C and
E for quantitation), indicating that these relatively
short transcripts utilized mostly the U snRNA pathway.
In contrast, the export of relatively long U1-derived
transcripts, in which a b-globin cDNA sequence of 200
or 300nt was inserted, was strongly inhibited by
CTE, but relatively weakly inhibited by PHAXNES
(Figure 1B, lanes 13–20, Figure 1D, lanes 9–12, and 1C
and E for quantitation), indicating that these relatively
long transcripts utilized mostly the mRNA pathway.
When the b-globin cDNA fragments were inserted in the
antisense orientation or when cDNA fragments derived
from the DHFR gene were employed, similar results
were obtained (see Supplementary data). These results
were in good agreement with the results obtained from
our previous RNA microinjection experiments (7,12),
and indicated that RNA length is an important deter-
minant of RNA identity in nuclear export, even in an
RNA export assay system that is coupled to in vivo
transcription.
To conﬁrm the importance of RNA length, we next
constructed plasmids in which cDNA sequences of various
lengths (50–360nt), without any U1 RNA sequence,
were sandwiched between the U1 promoter and the U1
terminator (Figure 2A). The resultant plasmids were
microinjected into the nucleus for similar RNA export
assays as in Figure 1. Consistent with the results in
Figure 1, the export of relatively short transcripts, in
which a b-globin cDNA sequence of 50 or 100nt was used,
was only weakly aﬀected by CTE, but relatively strongly
inhibited by PHAXNES (Figure 2B, lanes 5–12,
Figure 2D, lanes 5–8, and 2C and E for quantitation),
indicating the overall utilization of the U snRNA path-
way. In contrast, the export of relatively long transcripts,
in which a b-globin cDNA sequence of 200 or 360nt was
used, was strongly inhibited by CTE, but relatively weakly
inhibited by PHAXNES (Figure 2B, lanes 13–20,
Figure 2D, lanes 9–12, and 2C and E for quantitation),
indicating the overall utilization of the mRNA pathway.
Since the b360 construct produced multiple bands of
transcripts for unknown reason, the bands near the
expected size were quantiﬁed (Figure 2B and D, asterisks).
When the DHFR cDNA fragments were employed or
when the b-globin cDNA fragments were inserted in
the antisense orientation, similar results were obtained
(Figure 2F and Supplementary data).
To further conﬁrm that RNA length, independent of
RNA sequence, is important, 1–3 copies of a 100-nt DNA
fragment from the DHFR gene were cloned between the
promoter and terminator of the U1 gene (Figure 3A).
These plasmids were subjected to similar RNA export
assays. RNA export progressively shifted from U snRNA
export to mRNA export as the copy number increased,
as judged by the requirement for TAP and PHAX
proteins (Figure 3B, lanes 5–16, Figure 3D, lanes 5–16
and 3C, 3E for quantitation). These results strongly
suggested that RNA length per se, independent of RNA
sequence, is the determinant of the choice of RNA export
pathway.
Promoter sequence per sedoes nothave aclear influence
on thechoice of export pathwayof thetranscript
It should be pointed out that the eﬀect of RNA length on
the RNA export pathway choice was dominant over the
putative eﬀect, if any, of the U snRNA-type transcription
regulatory sequences (promoter and terminator). If the
transcript was long enough, it behaved like an mRNA
even though it was produced from the U snRNA-type
transcription unit (Figures 1–3). This means that tran-
scription from the U1 promoter or termination by the U1
terminator cannot induce U snRNA export in a dominant
manner.
Moreover, when the U1 RNA sequence was inserted
between the CMV promoter (an mRNA-type promoter)
and the U1 terminator (Figure 4A), and the resultant
plasmid was microinjected into the nucleus, the U1
transcript initiated from the CMV promoter and termi-
nated by the U1 terminator was clearly detected by
northern blotting (Figure 4B, lanes 5–8), although
transcription from mRNA-type promoters tends to read
through the U snRNA-type terminators (43,44). The U1
transcript produced from the plasmid behaved like a U
snRNA, as judged by the eﬀects of CTE and PHAXNES
(Figure 4B and D, lanes 5–8, and C and E for
quantitation), indicating that the CMV promoter could
not convert the U1 transcript to utilize the mRNA export
pathway. This was also the case with the plasmid in which
the b-globin cDNA sequence of 50nt was inserted between
the CMV promoter and the U1 terminator. The CMV
promoter could not convert the b50 transcript to utilize
the mRNA export pathway (Figure 4B and D, lanes 9–12,
and C and E for quantitation), conﬁrming that the CMV
promoter could not induce mRNA export in a dominant
manner. It should be pointed out that the eﬀect of RNA
length on the choice of RNA export pathway was also
clearly seen when the CMV promoter and the U1
terminator were employed (Figure 4B, lanes 9–24 and D,
lanes 9–16, and C and E for quantitation), further
conﬁrming the importance of RNA length in the export
pathway choice. Since the b360 construct produced
multiple bands of transcripts for unknown reason, the
bands near the expected size were quantiﬁed (Figure 4B
and D, asterisks). These results taken together strongly
suggest that the promoter sequence per se has no
signiﬁcant inﬂuence on the choice of export pathway of
the transcript. They also suggest that the terminators of
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of export pathway of the transcript.
Presence ofpoly (A)tail of appropriatelength can induce
mRNAexport in adominant manner
Surprising results were obtained from experiments in
which transcription of b-globin cDNA sequences of
various lengths was initiated from the CMV promoter
and terminated by the BGH poly (A) signal (Figure 5A).
Since transcripts that were not terminated at the BGH
poly (A) signal were present at signiﬁcant levels (data
not shown), only properly polyadenylated transcripts
were detected by northern blotting using a speciﬁc probe
(see ‘Materials and Methods’ section for details). When
the polyadenylated transcripts were speciﬁcally visualized,
the bands of the transcripts were smeared due to the
variation of the poly (A) tail length. Interestingly, the
transcripts with a very long poly (A) tail (>250nt)
appeared to be retained in the nucleus (Figure 5B). This
is most evident in lanes 13 and 14 of Figure 5B, in the area
above the 300nt marker. In contrast, the transcripts with
‘proper’ lengths of poly (A) tail were exported eﬃciently
(Figure 5B, lanes 1, 2, 5, 6, 9, 10, 13, 14). More
importantly, CTE strongly inhibited the export of poly-
adenylated RNAs overall, regardless of the lengths of the
cDNA sequences, while the export of the control U1 tran-
script was hardly aﬀected by CTE (Figure 5B, C and D
Figure 2. Eﬀect of RNA length on RNA export in the transcription-coupled system (II). (A) Diagram of the DNA constructs. Human b-globin
cDNA fragments of various lengths were cloned between the promoter and terminator of the U1 gene. The U1Sm gene was also used as a control.
(B) Export of the transcripts produced from the microinjected plasmids harboring the cDNA fragments of various lengths (50–360nt) between
the promoter and terminator of the U1 gene was analyzed as in Figure 1B. The U1Sm gene was also used as a control. The bands indicated by the
asterisk correspond to the 360-nt transcript whose 30-end was properly formed. (C) Quantitation of RNA export inhibition by CTE WT from the
experiments like that shown in B. Since the b360 construct produced multiple bands for unknown reason, the bands near the expected size were
quantiﬁed (B, asterisk). (D) Export of the transcripts produced from the microinjected plasmids harboring the cDNA fragments of 50 or 360nt
between the promoter and terminator of the U1 gene was analyzed as in Figure 1D. The U1Sm gene was also used as a control. The bands
indicated by the asterisk correspond to the 360-nt transcript whose 30-end was properly formed. (E) Quantitation of RNA export inhibition by
PHAXNES from the experiments like that shown in D. Since the b360 construct produced multiple bands, the bands near the expected size were
quantiﬁed (D, asterisk). (F) Similar experiments to those in C and E except that cDNA fragments from the DHFR gene instead of the b-globin gene
were used.
1042 Nucleic Acids Research, 2008, Vol. 36, No. 3for quantitation), suggesting that these polyadenylated
transcripts utilized mostly the mRNA export pathway.
Even the transcript with the shortest cDNA sequence
(b50) behaved overall like an mRNA. This unexpected
phenomenon appeared to be due to the presence of either
the CMV promoter or the poly (A) signal, and given the
results in Figure 4 showing that the CMV promoter had
no signiﬁcant inﬂuence, it was likely that the poly (A)
signal was responsible.
To conﬁrm that the poly (A) signal rather than the
CMV promoter was responsible for this phenomenon, the
behavior of the transcripts from two additional constructs
was examined. The ﬁrst construct had the CMV promoter
and the U1 terminator (Figure 6A, same as the b50
construct in Figure 4), and the second the U1 promoter
and the poly (A) signal (Figure 6B). Since transcription
from the U1 promoter tends to ignore the poly (A) signal
(42), only properly polyadenylated transcripts from the
second construct were detected by northern blotting
using a speciﬁc probe (see ‘Materials and Methods’
section for details). The transcript from the ﬁrst construct
behaved like a U snRNA (4.2% export inhibition by
CTE, Figure 6A, also see Figure 3C), whereas the tran-
script from the second construct behaved like an mRNA
Figure 3. Eﬀect of RNA length on RNA export in the transcription-coupled system (III). (A) Diagram of the DNA constructs. One to three copies
of a 100-nt DNA fragment from the DHFR gene were cloned between the promoter and terminator of the U1 gene. The U1Sm gene was also used
as a control. (B) Export of the transcripts produced from the microinjected plasmids harboring 1–3 copies of a 100-nt DNA fragment from the
DHFR gene between the promoter and terminator of the U1 gene was analyzed as in Figure 1B. The U1Sm gene was also used as a control.
(C) Quantitation of RNA export inhibition by CTE WT from the experiments like that shown in B. (D) Export of the transcripts produced from the
microinjected plasmids as in B was analyzed as in Figure 1D. The U1Sm gene was also used as a control. (E) Quantitation of RNA export
inhibition by PHAXNES from the experiments like that shown in D.
Nucleic Acids Research, 2008, Vol. 36, No. 3 1043Figure 4. Eﬀect of transcription from the CMV promoter on RNA export. (A) Diagram of the DNA constructs. Human b-globin cDNA fragments
of various lengths or the U1Sm sequence were cloned between the CMV promoter and U1 terminator. The U1Sm gene was also used as a
control. (B) Export of the transcripts produced from the microinjected plasmids harboring the cDNA fragments of various lengths (50–360nt) or the
U1Sm sequence between the CMV promoter and the U1 terminator was analyzed as in Figure 1B. The U1Sm gene was also used as a control.
The bands indicated by the asterisk correspond to the 360nt transcript whose 30-end was properly formed. (C) Quantitation of RNA export
inhibition by CTE WT from experiments like those shown in B. Since the b360 construct produced multiple bands for unknown reason, the bands
near the expected size were quantiﬁed (B, asterisk). (D) Export of the transcripts produced from the microinjected plasmids harboring the cDNA
fragments of 50 or 360nt or the U1Sm sequence between the CMV promoter and the U1 terminator was analyzed as in Figure 1D. The U1Sm
gene was also used as a control. The bands shown by the asterisk correspond to the 360nt transcript whose 30-end was properly formed.
(E) Quantitation of RNA export inhibition by PHAXNES from the experiment shown in D. Since the b360 construct produced multiple bands,
the bands near the expected size were quantiﬁed (D, asterisk).
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clearly indicated that it was the poly (A) signal that was
responsible. This conclusion was further conﬁrmed using
the third construct (Figure 6C). If the transcription of U5
snRNA was terminated by the poly (A) signal, the U5
transcript behaved like an mRNA (53% export inhibition
by CTE, Figure 6C), indicating that even a U snRNA
could be committed to the mRNA export pathway. These
results indicated that either the poly (A) signal-mediated
30-end processing or the presence of a poly (A) tail induced
mRNA export in the transcripts that should otherwise
behave like a U snRNA.
To distinguish between the above two possibilities, the
inhibitory eﬀect of CTE on the export of the polyadenyl-
ated b50 transcript was calculated and plotted as a
function of RNA length (Figure 7B, lanes 1–4 and 7C).
The inhibitory eﬀect of CTE, i.e. the degree of commit-
ment to mRNA export, was clearly positively correlated
with the RNA length, and hence the poly (A) tail length
(Figure 7C). The longer the poly (A) tail within the
measured range, the more strongly the RNA was
committed to mRNA export, strongly suggesting that
the presence of the poly (A) tail rather than the cleavage/
polyadenylation per se induced mRNA export. Again the
transcripts with very long poly (A) tails above the tested
range were retained in the nucleus (above the 300nt
marker, Figure 7B, lanes 1, 2).
To further conﬁrm that the presence of a poly (A) tail of
an appropriate length was responsible for inducing
mRNA export, an attempt was made to artiﬁcially shorten
the poly (A) tail of the transcript by microinjecting (dT)40
single-stranded DNA oligonucleotide into the nucleus,
since the (dT)40 should hybridize to poly (A) tails and the
endogenous RNaseH activity should then degrade the
poly (A) tails. As anticipated, the poly (A) tail length of
the transcript was signiﬁcantly shortened (Figure 7B, lanes
5–12). A large fraction of the transcript was seen around
the 100nt marker (Figure 7B, lanes 5–12), indicating that
this fraction had very short poly (A) tail. This poly (A)
shortening appeared to have occurred in the nucleus, since
the injected (dT)40 stayed in the nucleus (Figure 7B) and
since the vast majority of RNase H activity is nuclear (52).
Importantly, CTE hardly inhibited the export of this
fraction of the transcript (lanes 5–8) while PHAXNES
strongly inhibited its export (lanes 9–12), indicating that
this fraction of the transcript utilized the U snRNA
pathway. These results strongly suggest that the presence
of a poly (A) tail of appropriate length, rather than the
cleavage/polyadenylation per se, is important for inducing
mRNA export.
To examine whether the presence of poly (A) sequence
functions in inducing mRNA export independent of its
position, one or two copies of a DNA fragment containing
70-nt poly (A) sequence were inserted into the XhoI site of
the U1Sm gene. These plasmids were subjected to
similar RNA export assays. RNA export progressively
shifted from U snRNA export to mRNA export as the
poly (A) length increased, as judged by the requirement
for TAP protein (Figure 7E, lanes 5–12 and 7F for
quantitation). These results clearly indicated that the
presence of poly (A) sequence of appropriate length can
induce mRNA export independent of its position and
without the polyadenylation signal.
To conﬁrm that the changes in RNA export pathway
were reﬂected by the changes in export RNP composition,
immunoprecipitation with an anti-PHAX antibody (7,12)
was carried out to analyze the association of PHAX with
the transcripts (Figure 7G). When the transcripts were
produced from the U1 promoter and the U1 terminator,
relatively short transcripts (produced from the ﬁrst
three constructs, Figure 7G), which behaved overall like
Figure 5. Eﬀect of transcription from an mRNA transcription unit on
RNA export. (A) Diagram of the DNA constructs. Human b-globin
cDNA fragments of various lengths were cloned between the CMV
promoter and the poly (A) signal from the bovine growth hormone
(BGH) gene. The U1Sm gene was also used as a control. (B) Export
of the transcripts produced from the microinjected plasmids harboring
the cDNA fragments of various lengths (50–360nt) between the CMV
promoter and the BGH poly (A) signal was analyzed as in Figure 1B.
Only the polyadenylated transcripts were visualized (see ‘Materials
and Methods’ section). (C) The transcript from the plasmid harboring
the U1Sm gene was analyzed as a control as in Figure 1B.
(D) Quantitation of B and C.
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the b360 transcript (produced from the fourth construct),
which behaved like an mRNA, was poorly bound by
PHAX. Moreover, the polyadenylated b50 transcript
(produced from the last construct), which behaved overall
like an mRNA, was also poorly bound by PHAX. We
suspected that the association of Aly/REF with these
transcripts would be the opposite to that of PHAX, since
their binding to RNA is mutually exclusive (7,12).
However, the Aly/REF antibodies could not immunopre-
cipitate any transcripts above the background level in the
current DNA microinjection system, although the same
antibodies worked well in the RNA microinjection system
(7,12). The reason for this is not clear, but it may have
been because the amount of transcripts produced from the
microinjected plasmids was much smaller than the amount
of RNA used in the RNA microinjection experiments. In
any case, these results with the anti-PHAX antibody were
in good agreement with the changes of RNA export
pathway in response to changes of the RNA length and
the presence of the poly (A) tail.
DISCUSSION
Importanceof RNA length in determining mRNA identity
fornuclear export
In this report, we ﬁrst showed unequivocally that RNA
length is an important determinant of the choice of
RNA export pathway, even in a transcription-coupled
RNA export assay system. Regardless of whether the
transcription was initiated from an mRNA-type promoter
or a U snRNA-type promoter, relatively short tran-
scripts preferentially recruited a U snRNA export factor,
PHAX, and therefore they were committed overall to the
U snRNA export pathway, whereas relatively long
transcripts did not associate with PHAX and they were
committed overall to the mRNA export pathway
(Figures 1–4). Neither the CMV nor the U1 promoter
could override this RNA length eﬀect (Figures 1–4),
suggesting that transcription does not aﬀect the recruit-
ment of export factors onto the RNA in our assay system.
This is consistent with the fact that splicing rather
than transcription has a role in loading export factors
onto RNA in vertebrates (13,31,33–35). Accordingly, our
initial hypothesis that transcription from the correspond-
ing promoter may inﬂuence the RNA identity was
disproved.
It was surprising to ﬁnd that RNA length had a similar
eﬀect on the choice of RNA export pathways in both the
transcription-coupled system and the RNA microinjection
system, since the transcript would gradually emerge from
the plasmids in the transcription-coupled system, whereas
an RNA with a deﬁned length is introduced into the
nucleus in the RNA microinjection system. These results
indicate that the features of the transcribed RNAs, rather
than the ways they are transcribed, are important for
determining the RNA identity for nuclear export.
However, these results do not necessarily mean that the
RNA identity is determined only after the transcription is
completed. If the RNA contains an intron, it may be
spliced before the transcription termination (45,46). In
that case, the RNA may immediately qualify as an
mRNA, even before the transcription termination. Also,
in the case of intronless mRNAs, as soon as a relatively
unstructured RNA region of few hundreds nucleotides
has been generated during transcription, the RNA may
immediately qualify as an mRNA. Since the binding
of an mRNA export factor, Aly/REF, and a U snRNA
export factor, PHAX, to a given RNA is mutually
Figure 6. Eﬀect of 30-end processing signals on RNA export. Export of the transcripts produced from the plasmids harboring the b-globin 50-nt
cDNA fragment between the CMV promoter and the U1 terminator (panel A) or between the U1 promoter and the BGH poly (A) signal (panel B),
or from the plasmid harboring the U5 snRNA sequence between the U1 promoter and the BGH poly (A) signal (panel C) was analyzed as in
Figure 5.
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PHAX is ﬁrst recruited to the cap structure of mRNAs at
the very early stage of transcription but is released from
the RNA as soon as the RNA qualiﬁes as an mRNA.
Role ofthe poly(A) tail inmRNA nuclear export
Transcription termination by the U1 snRNA gene
terminator had no signiﬁcant eﬀect on the choice of
RNA export pathway (Figures 1 and 2). In contrast,
transcription termination by the poly (A) signal had a
signiﬁcant dominant eﬀect to induce mRNA export of the
transcript. What is responsible for inducing mRNA export
is not the cleavage/polyadenylation per se but the presence
of a poly (A) tail of an appropriate length (Figures 5–7).
When the short b50 transcript was polyadenylated in vivo,
the transcript lost aﬃnity for PHAX and utilized mostly
the mRNA export pathway (Figure 7B, C and G).
Moreover, the longer the poly (A) tail within a certain
range, the more the transcript behaved like an mRNA
Figure 7. Eﬀect of poly (A) tail length on RNA export. (A) Diagram of the DNA construct as in Figure 6B is shown. (B) Eﬀect of CTE and
PHAXNES on export of the transcript from the plasmid was analyzed. For lanes 5–12, 0.8pmol/oocyte of (dT)40 was coinjected with the plasmid.
RNA length markers are shown on the left. The range of RNA length quantiﬁed in C is marked. (C) The RNA export inhibition by CTE observed in
B, lanes 1–4, was calculated and plotted as a function of RNA length in the marked range in B. (D) One or two copies of a DNA fragment
containing 70-nt poly (A) sequence were inserted into the XhoI site of the U1Sm gene. (E) Eﬀect of CTE on export of the transcripts from the
plasmids was analyzed. (F) Quantitation of RNA export inhibition by CTE from the experiments like that shown in E. (G) Various DNA constructs
indicated in the table were microinjected into the nucleus of Xenopus oocytes. The nuclear fraction was prepared after 3h, and immunoprecipitation
was performed with either anti-PHAX antibody (a-PHAX) or anti-mouse IgG antibody (control). The co-precipitated RNA was recovered and
analyzed by real-time RT-PCR. The eﬃciency of immunoprecipitation by each antibody is shown on the right.
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could induce mRNA export independent of its position
(Figure 7D–F). This may mean that the poly (A) sequence
simply contributes to increasing the RNA length. In fact,
the polyadenylated b50 transcript (total length,  200nt)
behaved very similarly to the b200 transcript without
a poly (A) tail (total length,  200nt) in nuclear export
(60% export inhibition by CTE, Figure 2). Hence it is not
possible to say that the eﬀect of poly (A) sequence is
stronger than the RNA length eﬀect.
Although the poly (A) sequence can induce mRNA
export, when the poly (A) tail was very long (>250nt), the
transcript was not transported to the cytoplasm but rather
retained in the nucleus (Figures 5–7). Similar observations
were made in previous studies using yeast mutant strains
in which hyper-adenylated mRNAs are retained at the
transcription gene loci via the action of the nuclear
exosome. These observations indicate the existence of a
checkpoint mechanism that controls the quality of
mRNAs by blocking or allowing their nuclear export
(53–55). Our result suggests that such a mechanism is
evolutionarily conserved in vertebrates.
Alternatively, the poly (A) tail may not simply
contribute to increase the RNA length, since the poly
(A) tail is thought to be covered by poly (A) binding
protein(s) (56,57), and therefore mRNA export factors
may not be able to directly bind to the poly (A) tail. It is
possible that a poly (A) tail of an appropriate length may
function as a platform to recruit mRNA export factors. In
this latter scenario, poly (A) binding protein(s) should
function in recruiting mRNA export factors. The impor-
tance of the poly (A) tail and its binding proteins (Pab1p
and Nab2p) has been already suggested in yeast (reviewed
in 56,57). Although the nuclear functions of the yeast poly
(A) binding proteins appear to be related to poly (A) tail
length control and therefore to the above-mentioned
exosome-mediated quality control mechanism, rather
than to mRNA export per se (58–62), some studies
suggested more direct role of Nab2p in mRNA export
(63–65). The vertebrate homolog of yeast Nab2p, how-
ever, has not been identiﬁed to our knowledge. In any
case, our ﬁnding clearly demonstrates that the poly (A)
tail is directly linked to the mRNA export pathway in
vertebrates, and it remains to be investigated whether the
poly (A) tail simply contributes to increasing the RNA
length or plays more active role in mRNA export.
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